Professional Documents
Culture Documents
Soft Tissue Tumors Diagnosis, Evaluation, And.3
Soft Tissue Tumors Diagnosis, Evaluation, And.3
and Management
Franklin H. Sim, MD, Frank J. Frassica, MD, and Deborah A. Frassica, MD
Abstract
Benign soft-tissue neoplasms and tumorlike conditions of the musculoskeletal sys- Obtaining a thorough history is
Downloaded from http://journals.lww.com/jaaos by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3i3D0OdRyi7TvSFl4Cf3VC4/OAVpDDa8K2+Ya6H515kE= on 10/05/2021
tem are common. Sarcomas are less frequent, with only 5,000 new cases diagnosed an important first step in manage-
each year in the United States. After plain radiographs of the affected area have ment. The following questions are
been obtained, magnetic resonance (MR) imaging (both T1- and T2-weighted important guides to establishing a
sequences) is the best imaging modality for detecting and characterizing the lesion. differential diagnosis:
Although MR imaging is not specific in determining whether lesions are benign or
malignant, it can be useful in evaluating other characteristics, such as size, pattern How long has the mass been present?
of growth, integrity of natural boundaries, and homogeneity. Biopsy must be done Masses that have been present for
carefully, so as not to adversely affect the outcome. Technical considerations long periods of time are most likely
include proper location and orientation of the biopsy incision, meticulous hemo- benign. Examples include lipomas
stasis, and frozen-section analysis to ensure that diagnostic material has been and hemangiomas. A new mass that
obtained. Effective treatment requires close coordination between the surgeon, the has arisen over a short period must
radiation oncologist, the pathologist, the plastic surgeon, and the diagnostic radi- raise the index of suspicion of malig-
ologist. Limb-salvage surgery has resulted in a local control rate greater than 90%. nancy. However, some malignant
High-grade tumors that are larger than 5 cm in diameter have the worst progno- neoplasms (e.g., synovial sarcomas)
sis. The role of chemotherapy remains controversial and unresolved. may be present for a number of
J Am Acad Orthop Surg 1994;2:202-211 years, and their chronic nature may
be misleading to the clinician.
Benign soft-tissue neoplasms and in the soft tissues. The clinician must Is the mass enlarging in size?
tumorlike conditions of the muscu- maintain an appropriate index of An increase in the size of a mass
loskeletal system are common and suspicion to make an early diagnosis indicates an active process. Malignant
include entities such as lipomas, of malignant neoplasm while being neoplasms tend to grow progres-
hemangiomas, and giant cell tumors careful not to expend valuable sively. However, lesions that are not
of the tendon sheath. Malignant resources on lesions that are neither enlarging may still be malignant.
lesions, such as soft-tissue sarcomas, aggressive nor malignant. Effective Patients often have difficulty assess-
are less frequent, with only 5,000 new management depends on a knowl- ing the true growth pattern, as masses
cases each year in the United States. edge of the classification and staging
There are many different causes of of soft-tissue tumors and consistent Dr. Sim is Professor of Orthopaedic Surgery and
soft-tissue masses (Table 1). The prin- use of strategies for evaluation, Oncology, Mayo Clinic, Rochester, Minn. Dr.
cipal types are (1) soft-tissue tumors biopsy, and treatment of both Frank Frassica is Associate Professor of
Orthopaedics and Oncology, Johns Hopkins Uni-
and tumorlike conditions, (2) bone benign and malignant neoplasms.
versity, Baltimore. Dr. Deborah Frassica is
tumors that have penetrated the bone Assistant Professor of Radiation Oncology, East-
compartment and formed a soft-tis- ern Virginia Medical School, Portsmouth, Va.
Diagnosis and Evaluation
sue mass, and (3) surface tumors of
bone that have arisen from the cortex Clinical Presentation Reprint requests: Dr. Sim, Department of
Orthopaedic Surgery, Mayo Clinic, 200 First
and periosteal tissues and grown into Patients with a soft-tissue tumor
Street Southwest, Rochester, MN 55905.
the soft-tissue compartment. generally present to their physician
The purpose of this review is to complaining of a lump, bump, or Copyright 1994 by the American Academy of
discuss the diagnosis, evaluation, growth. Pain may be an accompa- Orthopaedic Surgeons.
and management of masses arising nying symptom.
Table 1
body, an infection, or a pseudo- rocklike consistency. Epithelioid
Functional Classification of aneurysm. Nonpenetrating trauma sarcoma often presents as a small,
Soft-Tissue Masses can result in heterotopic bone forma- superficial nodule, which may ulcer-
tion. Antecedent trauma has been ate. Clear cell sarcoma also presents
Tumors and tumorlike conditions associated with the development of as a small nodule along a tendon
arising in the soft tissues desmoid tumors (extra-abdominal sheath. When a mass is located in
Benign neoplasms fibromatosis).1 the region of a major blood vessel,
Lipomas the clinician should palpate the mass
Hemangiomas Is there a history of cancer? to detect pulsations and should lis-
Fibromatosis
Malignant neoplasms, such as ten for a bruit to exclude a pseudo-
Malignant neoplasms
breast and lung carcinomas, aneurysm or an arteriovenous
Sarcomas
Metastatic carcinomas melanomas, and lymphomas, may malformation.
Tumorlike conditions metastasize to the soft tissues. One must carefully examine the
Heterotopic ossification entire extremity in which there is a
Tumoral calcinosis Is there a history of systemic signs and soft-tissue mass. Malignant neo-
Intramedullary bone tumors symptoms? plasms may have satellite lesions in
Benign neoplasms (giant cell Systemic symptoms such as fever, the vicinity of the predominant
tumor) chills, and malaise may be secondary lesion. Regional and other lymph-
Malignant neoplasms to an abscess. Malignant neoplasms, node sites (cervical, supraclavicular,
Osteosarcoma such as lymphomas, Ewing’s sar- axillary, and inguinal) must also be
Ewing’s sarcoma
coma, and extramedullary plasmacy- examined. Malignant neoplasms
Lymphoma
toma, may also result in systemic that are more likely to metastasize to
Myeloma
Tumorlike conditions symptoms. Angiosarcomas may lymph nodes include synovial sarco-
(aneurysmal bone cyst) cause microangiopathic hemolytic mas, rhabdomyosarcomas, epithe-
Surface bone tumors anemia (Kasabach-Merritt syn- lioid sarcomas, and clear cell
Benign neoplasms drome). sarcomas. The clinician should
Osteochondroma examine the abdomen to detect
Periosteal chondroma Is there a family history of soft-tissue hepatomegaly or splenomegaly.
Malignant neoplasms masses?
Parosteal osteosarcoma Several conditions (e.g., neuro- Classification and Staging
Periosteal osteosarcoma fibromatosis, lipomas, and heman- Systems
giomas) have a pattern of familial Soft-tissue tumors are most com-
inheritance (Table 2). monly classified according to the
in certain locations may not be noticed direction of cellular differentiation.
until they are of substantial size. Physical Examination There are over 200 types of benign
Careful physical examination is lesions and 70 types of malignant
Is the mass causing pain? important, as there may be several lesions. The more common lesions
Sarcomas often cause pain sec- findings that suggest the possibility that orthopaedic surgeons encounter1
ondary to inflammation in the reac- of a malignant neoplasm. Lesions are outlined in Table 3.
tive zone of the tumor. Lesions that that are large (greater than 5 cm), Benign lesions can be classified
invade the periosteum may also firm, deep-seated, and fixed to into three categories.2 Stage 1 lesions
cause pain. Abscesses are often underlying tissues suggest a malig- are latent or inactive. Stage 2 lesions
painful. Sarcomas may undergo nant process. Moderate tenderness are active and growing or causing
necrosis and hemorrhage within also is compatible with a malignant symptoms. Stage 3 lesions are
their substance, causing severe acute process, as there is often an active aggressive and are characterized by
pain accompanied by a marked inflammatory process within the their large size and penetration of
increase in size; thus, they may sim- reactive zone of the tumor. Small anatomic boundaries.
ulate an abscess or muscle trauma. superficial and mobile lesions are Malignant soft-tissue tumors have
more likely to be benign. a centripetal pattern of growth (Fig.
Is there any history of penetrating or Several tumors have distinct fea- 1), expanding and penetrating natural
nonpenetrating trauma? tures on physical examination. barriers such as muscle, fascia, and
A history of penetrating trauma Extra-abdominal fibromatosis (des- periosteum. Surrounding the tumor is
suggests the presence of a foreign moid) tumors frequently have a an interface between the tumor and
Fibrous
normal tissues termed the “reactive Palmar, plantar, and penile Occasionally in several generations
zone,” which contains edema fluid, fibromatosis of one family and in twins
inflammatory cells, fibrous tissue, Fatty
and tumor-cell satellites. Lipoma About 5% familial
Malignant lesions are often graded Angiolipoma About 5% familial
on the basis of morphologic character- Fibrohistiocytic
istics within a given histologic entity. Xanthoma tuberosum Occurs in familial hyperlipidemia
The surgical staging system devel- Tendinous xanthoma Occurs in familial hyperlipidemia
and in cerebrotendinous
oped by the Musculoskeletal Tumor
xanthomatosis inherited as an
Society is based on the grade of the
autosomal-recessive trait
lesion, local extension (intracompart- Muscular
mental or extracompartmental), and Cutaneous leiomyoma Occasional familial cases with a
the presence or absence of metastases pattern suggesting autosomal-
(Table 4).3 An alternative staging sys- dominant mode of inheritance
tem proposed by the American Joint Vascular
Committee is also based on the grade, Glomus Occasional familial cases following
local extension, size, and presence or an autosomal-dominant mode of
absence of regional or distant metas- inheritance
tases (TNM system). Osler-Weber-Rendu syndrome Autosomal-dominant inheritance
(hereditary hemorrhagic
The most common malignant
telangiectasia)
lesions can be categorized in a func-
Blue rubber-bleb nevi (cavernous Some cases follow autosomal-
tional classification system (Table hemangiomas of the skin and dominant mode of inheritance
5) as graded sarcomas, nongraded gastrointestinal tract)
sarcomas, and small cell neoplasms Neural or neuroectodermal
(H. M. Reiman, MD, personal com- Neurofibromatosis (von Autosomal-dominant inheritance
munication, June 1994). Graded Recklinghausen’s disease) with a high rate of spontaneous
sarcomas range from well-differen- mutation
tiated tumors to high-grade Neuroblastoma Rare familial cases
anaplastic tumors. Nongraded Miscellaneous
tumors tend to behave aggres- Fibrodysplasia (myositis) Occasional familial cases
ossificans progressiva
sively. Small cell neoplasms are
Tumoral calcinosis Occasional familial cases
responsive to both external-beam
irradiation and chemotherapy. * Adapted with permission from Enzinger FM, Weiss SW: Soft Tissue Tumors.
Surgical procedures can also be Philadelphia: CV Mosby, 1983, p 2.
classified according to the system
Table 3
Histologic Classification of Common Soft-Tissue Tumors*
*Adapted with permission from Enzinger FM, Weiss SW: Soft Tissue Tumors. Philadelphia, CV Mosby: 1983, pp 6–7.
Treatment
aries and its relationships with adja- mal tissue without compromise of
cent structures (nerves, arteries, local control or ultimate survival.14-16
veins, fascia planes, and muscles). Irradiation can be delivered with
The CT study is most useful in deter- the use of (1) a high-energy external
mining whether there is any erosion beam in the pre- and/or postopera-
or destruction of underlying bone. tive period, (2) brachytherapy utiliz-
Angiography can be performed to ing afterloading catheters placed
define the vascularity of the lesion during the operative procedure,
and to detect encasement of a major (3) intraoperative electron therapy,
vessel. As the resolution of MR or (4) a combination of these proce-
imaging has improved, the indica- dures. External-beam techniques
tions for angiography have dimin- are the most widely available and
ished. most commonly used. The use of
The surgical procedures are high-dose postoperative irradiation
designed to remove the lesion with a (60 to 65 Gy) is associated with a
cuff of normal tissue (wide surgical decreased risk of wound complica-
margin). If a major vessel is encased tions, but generally treatment with
by the tumor, it may be necessary to larger fields is required because the
resect and reconstruct the vessel. If entire surgical bed must be included.
cortical bone destruction is present, Compared with postoperative ther-
the involved bone must also be apy, preoperative treatment often
removed with a wide margin. If the improves the resectability of lesions,
major nerves of the limb are sur- allows treatment of smaller vol-
rounded by tumor, amputation is umes, and has been associated with
Fig. 5 Diagram of a lesion in the lateral
aspect of the quadriceps mechanism. A probably necessary, because the better local control rates for larger
short longitudinal incision is made over the limb will not be functional with a lesions.14
lesion. Prior to incising the skin, a second limb-salvage procedure. Brachytherapy has been used to
incision line should be drawn, to demon-
strate how the biopsy tract can be removed The second phase of surgery is deliver the total radiation dose15 with
at the time of the definitive surgery. reconstruction. The surgical defect excellent results. However, many
must be carefully closed to minimize lesions are not amenable to a pri-
the risk of fluid collections and mary en bloc resection without the
ation oncologist, the medical oncolo- delayed wound healing. When nec- sacrifice of crucial structures (e.g.,
gist, the plastic surgeon, and the tho- essary, large defects should be vessels, nerves, tendons). There is
racic surgeon. closed with either local rotational also concern about dose homogene-
muscle flaps or free microvascular ity with large-volume implants.
Surgery of Malignant Lesions tissue transfers. Split-thickness skin Therefore, brachytherapy and intra-
When appropriate, limb salvage grafts should be utilized when there operative techniques are most often
is the preferred technique for malig- is a defect with underlying healthy used as a substitute for a portion of
nant extremity lesions. The two pre- muscle. the external-beam treatment. These
requisites for limb-salvage surgery techniques allow delivery of a high
are that (1) local control of the lesion Radiation Therapy dose of radiation to a well-defined
will be at least equal to that achiev- Radiation therapy plays a major area and can be done at surgery or in
able with amputation, and (2) the role in the treatment of soft-tissue the immediate postoperative period
salvaged limb will be functional. sarcomas following limb-salvage rather than waiting 4 to 6 weeks for
Preoperative planning is crucial surgery. Although surgery alone adequate wound healing before
to ensure success. The MR imaging may yield good results in patients additional external-beam treatment.
and CT studies should be reviewed with small lesions,13 soft-tissue sarco- In the case of large or marginally
to accurately define the tumor vol- mas are often very large and located resectable lesions, preoperative
ume in order to determine whether too close to major nerves, vessels, external-beam radiation (50 to 55
the lesion will be resectable with a and bone to obtain sufficient mar- Gy) is generally used, followed by
limb-salvage procedure. The MR gins. The use of adjuvant irradiation an additional 10 to 15 Gy of radiation
images are most useful in determin- in the pre- or postoperative period delivered intra- or perioperatively to
ing the size of the tumor, its bound- allows the surgeon to conserve nor- areas of close margins. If these tech-
niques are not feasible or available, overall survival. 18,19 Other trials Chest radiographs and CT scans
an additional 15 Gy may be given to have not shown any significant should be obtained at 3-month inter-
a boost field by means of an external benefit.20-22 At present, the lower rate vals for 2 years and then at 6-month
beam. Local control rates with a of metastatic spread with low-grade intervals for 6 years. At 8 years after
combined-modality approach have lesions may not justify the potential surgery, they should be obtained
been reported to be 90% or risks of chemotherapy. once a year.
greater. 13,15,16 However, combined- Preoperative intra-arterial chemo-
modality treatments are not without therapy with or without irradiation Prognosis
potential complications; the compli- also has been studied in a number of
cation rate may approach 30%, espe- institutions, but the benefit of these The prognosis for the individual
cially with very large lesions treated techniques to later survival has not patient depends on the grade and
with preoperative irradiation. yet been established in randomized size of the tumor and the absence or
In cases in which an excisional trials.23 presence of metastases. Large
biopsy reveals a high-grade soft-tis- Adjuvant chemotherapy given (greater than 5 cm in diameter) and
sue sarcoma and MR imaging preoperatively, both pre- and post- high-grade lesions have a high poten-
reveals no evidence of gross residual operatively, or postoperatively is tial for metastasis. Pulmonary metas-
disease, reoperation with placement being studied prospectively in a tases develop in as many as 50% of
of afterloading catheters and deliv- number of institutions. Effective patients with high-grade lesions, and
ery of 15 to 20 Gy of radiation fol- chemotherapy agents and regimens these patients subsequently die of the
lowed by 45 Gy of postoperative continue to be sought as a method disease. The overall 5-year survival
external-beam treatment may be of improving survival, as has been rate for patients with high-grade
used. Preoperative external-beam documented in patients with intra- lesions but only localized disease is
irradiation alone is an alternative in medullary osteosarcoma, Ewing’s approximately 70% to 80%.
this situation.17 tumor, and rhabdomyosarcoma. Patients who have pulmonary
metastases at presentation or within 6
Chemotherapy Follow-up months of diagnosis have an
The role of adjuvant chemother- Patients should be monitored extremely poor prognosis, with only
apy in the treatment of high-grade closely following treatment and the rare long-term survivor. Pul-
soft-tissue sarcomas (with the then at 3-month intervals for 2 years monary resection of metastases is fea-
exception of Ewing’s sarcoma and with careful physical examination sible when there are no extrathoracic
rhabdomyosarcoma) continues to to detect local recurrence. A base- metastases and the primary tumor is
be the subject of investigation. Only line MR imaging study should be under control.24 Patients in whom
two prospective, randomized trials obtained 3 months after surgery; pulmonary metastases develop 1
of adjuvant chemotherapy in MR imaging should then be per- year after tumor resection may be
extremity lesions have shown formed at 1-year intervals for 5 cured with multiple thoracotomies in
improvement in disease-free and years thereafter. about 25% of cases.
References
1. Enzinger FM, Weiss SW: Soft Tissue mining the extent of disease. AJR 9. Petasnick JP, Turner DA, Charters JR, et
Tumors. St Louis: CV Mosby, 1983, pp 5-7. 1988;150:615-620. al: Soft-tissue masses of the locomotor
2. Enneking WF: Musculoskeletal Tumor 6. Richardson ML, Kilcoyne RF, Gille- system: Comparison of MR imaging
Surgery. New York: Churchill Living- spy T III, et al: Magnetic resonance with CT. Radiology 1986;160:125-133.
stone, 1983, vol 1, pp 14-19. imaging of musculoskeletal neo - 10. Ehman RL, Berquist TH, McLeod RA:
3. Enneking WF, Spanier SS, Goodman plasms. Radiol Clin North Am MR imaging of the musculoskeletal sys-
MA: A system for the surgical staging of 1986;24:259-267. tem: A 5-year appraisal. Radiology
musculoskeletal sarcoma. Clin Orthop 7. Pettersson H, Gillespy T III, Hamlin DJ, 1988;166:313-320.
1980;153:106-120. et al: Primary musculoskeletal tumors: 11. Mankin HJ, Lange TA, Spanier SS: The
4. Sundaram M, McLeod RA: MR imaging Examination with MR imaging com- hazards of biopsy in patients with malig-
of tumor and tumorlike lesions of bone pared with conventional modalities. nant primary bone and soft-tissue tumors.
and soft tissue. AJR 1990;155:817-824. Radiology 1987;164:237-241. J Bone Joint Surg Am 1982;64:1121-1127.
5. Demas BE, Heelan RT, Lane J, et al: 8. Kransdorf MJ, Jelinek JS, Moser RP Jr, et 12. Simon MA: Biopsy of musculoskeletal
Soft-tissue sarcomas of the extremities: al: Soft-tissue masses: Diagnosis using tumors. J Bone Joint Surg Am 1982;64:
Comparison of MR and CT in deter- MR imaging. AJR 1989;153:541-547. 1253-1257.
13. Karakousis CP, Emrich LJ, Rao U, et total excision of soft-tissue sarcomas. J 21. Edmonson JH: Role of adjuvant
al: Selective combination of modali- Clin Oncol 1985;3:1344-1348. chemotherapy in the management of
ties in soft tissue sarcomas: Limb sal- 18. Rosenberg SA, Tepper J, Glatstein E, patients with soft tissue sarcomas. Can-
vage and survival. Semin Surg Oncol et al: Prospective randomized evalu- cer Treat Rep 1984;68:1063-1066.
1988;4:78-81. ation of adjuvant chemotherapy in 22. Alvegård TA, Sigurdsson H, Mourid-
14. Tepper JE, Suit HD: Radiation therapy adults with soft tissue sarcomas of sen H, et al: Adjuvant chemother-
alone for sarcoma of soft tissue. Cancer the extremities. Cancer 1983;52: apy with doxorubicin in high-grade
1985;56:475-479. 424-434. soft tissue sarcoma: A randomized
15. Brennan MF, Hilaris B, Shiu MH, et al: 19. Gherlinzoni F, Bacci G, Picci P, et al: A trial of the Scandinavian Sarcoma
Local recurrence in adult soft-tissue sar- randomized trial for the treatment of Group. J Clin Oncol 1989;7:1504-
coma: A randomized trial of brachyther- high-grade soft-tissue sarcomas of the 1513.
apy. Arch Surg 1987;122:1289-1293. extremities: Preliminary observations. J 23. Bramwell VHC: Intraarterial chemo-
16. Sim FH, Pritchard DJ, Reiman HM, et Clin Oncol 1986;4:552-558. therapy of soft-tissue sarcomas. Semin
al: Soft-tissue sarcoma: Mayo Clinic 20. Edmonson JH, Fleming TR, Ivins J, et al: Surg Oncol 1988;4:66-72.
experience. Semin Surg Oncol 1988; Randomized study of systemic chem- 24. Creagan ET, Fleming TR, Edmonson JH,
4:38-44. otherapy following complete excision of et al: Pulmonary resection for metasta-
17. Giuliano AE, Eilber FR: The rationale for nonosseus sarcomas. J Clin Oncol tic nonosteogenic sarcoma. Cancer
planned reoperation after unplanned 1984;2:1390-1396. 1979;44:1908-1912.